Simulations Plus, Inc. (AMEX: SLP), the leading provider of ADMET absorption simulation and structure-to-property prediction software for pharmaceutical discovery and development, announced today that it has terminated its former investor relations agreement with Cameron Associates Inc. and will move this function in-house.

Walt Woltosz, chairman and chief executive officer of Simulations Plus, said, “As the company has grown and we have learned more about how to handle investor relations issues, we have decided to do as many other companies have done and bring this function in-house. We believe that this will provide greater shareholder value through both a significant cost savings, as well as allowing a greater number of person-hours to be applied to this function to provide a more active IR program.”